Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting

International Organization for the Study of Inflammatory Bowel Disease

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)6-13.e6
JournalGastroenterology
Volume159
Issue number1
DOIs
StatePublished - Jul 2020

Funding

FundersFunder number
Broad Medical Research Program
GlaxoSmithKline Services
Prometheus Laboratories
Techlab Inc.
UCB Biopharma SRL
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Gilead Sciences
Janssen Biotech
Celgene
AbbVie
Shire
Takeda Pharmaceuticals U.S.A.
Allergan
Janssen Pharmaceuticals
Prometheus
Crohn's and Colitis Australia
Crohn's and Colitis Foundation
Union Chimique Belge
Shire

    Cite this